Protecting your privacy is important to us. This Privacy Policy outlines how we collect, use, and safeguard your personal information in connection with our clinical trial for Female Sexual Arousal Disorder (FSAD).
Information Collection
We collect personal information from participants as necessary for the purpose of conducting the clinical trial. This may include contact information, medical history, and other relevant data related to FSAD symptoms and treatment.
Use of Information
We use the information collected to assess eligibility for the trial, provide personalized care and support, monitor participant progress, and gather data for research purposes. Your information may also be shared with authorized personnel involved in the trial and regulatory authorities as required by law.
Data Security
We take appropriate measures to protect the security and confidentiality of your personal information. This includes physical, technical, and administrative safeguards to prevent unauthorized access, disclosure, alteration, or destruction of data.
Data Retention
We retain personal information for the duration necessary to fulfill the purposes outlined in this Privacy Policy and as required by applicable laws and regulations. Upon completion of the trial, we may securely dispose of or anonymize your information in accordance with our data retention policies.
Updates to Privacy Policy
We may update this Privacy Policy from time to time to reflect changes in our practices or legal requirements. We encourage you to review this policy periodically for any updates.
If you have any questions or concerns about our Privacy Policy or the handling of your personal information, please contact us.
